Search for: "State of Oklahoma v. United States of America et al" Results 41 - 52 of 52
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Oct 2019, 9:33 am by Jeffrey Mitchell
Congress has reportedly authorized $550 million in the United States Department of Agriculture (USDA) ReConnect funding in 2019 (as compared to $600 million in 2018). [read post]
12 Jan 2017, 7:01 am by John Elwood
Amgen Inc., et al., 15-1039 and Amgen Inc. v. [read post]
20 Jun 2023, 7:09 pm by Jacob Fishman
Part V concludes with a report card on how the regime is doing on its thirtieth anniversary. [read post]
Oklahoma and 18 other states write that data from colleges where race-conscious admissions is banned show that schools can maintain diversity and academic competitiveness without it. [read post]
7 Jul 2023, 1:03 pm by Ryan Goodman
United States Secret Service, USSS Timeline of Jan. 6, 2021 (FOIA release on Jun. 29, 2021) 9. [read post]
1 Jun 2021, 7:15 am by Patricia Hughes
Les Québécoises et les Québécois forment une nation. [read post]
16 Dec 2016, 1:43 pm by Chuck Cosson
  Even under the appropriately exacting standards of New York Times v. [read post]
26 Mar 2007, 7:06 am
Most notably, he served for more than a year as lead technology consultant to the major tobacco companies in United States of America v. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
15 Feb 2008, 9:00 am
: (Spicy IP),USD 20 billion going off-patent: (Patent Circle),Canadian Prices Review Board asserts jurisdiction over products sold in US, but imported into Canada under Special Access Program: (Gowlings),Canadian Court of Appeal affirms decision allowing patent-owner to be joined to proceedings: Cobalt v Pfizer and Pharmascience v Pfizer: (Gowlings),PharmaStem appeals stem cell patent: asks for greater deference to patent examiners:… [read post]